We’ve all heard the advice that you should never accept the first offer. This wisdom is especially true in the world of used ...

Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$400 million aggregate principal amount of 4.500 percent ...

The Notes offering is expected to close on March 13 ... Notes or 2026 Notes that we purchase who have hedged their equity price risk with respect to such 2025 Notes or 2026 Notes will unwind ...

The Notes Offering is expected to close on or about ... (as will be defined in the indenture of the Notes), at a repurchase price equal to 100% of the principal amount of the Notes to be ...

Tarsus Pharmaceuticals (NASDAQ:TARS) priced an upsized underwritten public offering of 2.81M shares of its common stock at a public offering price of $44.50 per share. Underwriters have a 30-day ...

ZURICH, March 13, 2025 /PRNewswire/ -- Amcor plc (NYSE:AMCR; ASX:AMC) ("Amcor") announced today that Amcor Flexibles North America, Inc. ("AFNA"), a wholly-owned subsidiary of Amcor, has priced a ...

Shuttle Pharma intends to use the net proceeds from the Offering to fund Shuttle Pharma’s Phase II clinical trial for its lead product candidate, for marketing and advertising services, and for ...

Of course, there's also the possibility that they won't have similar specifications. Reports suggest that the S25 Edge might ...

of its 6.25% Series D Mandatory Convertible Preferred Stock (the “mandatory convertible preferred stock”) at a price to the public and liquidation preference of $50.00 per share. The offering ...

The offering is expected to close on or about March 13, 2025, subject to customary closing conditions. Nutrien intends to use the net proceeds from this offering to repay its US$500 million ...